SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-20-000154
Filing Date
2020-09-09
Accepted
2020-09-09 08:32:50
Documents
16
Period of Report
2020-09-09
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20200909.htm   iXBRL 8-K 42745
2 PRESS RELEASE a202009098-kex991.htm EX-99.1 22045
8 LOGO pdllogoa3511.jpg GRAPHIC 123123
  Complete submission text file 0000882104-20-000154.txt   381576

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20200909.xsd EX-101.SCH 2405
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20200909_cal.xml EX-101.CAL 698
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20200909_def.xml EX-101.DEF 1631
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20200909_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20200909_pre.xml EX-101.PRE 12634
9 EXTRACTED XBRL INSTANCE DOCUMENT pdli-20200909_htm.xml XML 10786
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 201165562
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences